These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31173889)

  • 21. Surveillance of antimicrobial susceptibilities reveals high proportions of multidrug resistance in toxigenic Clostridium difficile strains in different areas of Poland.
    Lachowicz D; Pituch H; Wultańska D; Kuijper E; Obuch-Woszczatyński P
    Anaerobe; 2020 Apr; 62():102167. PubMed ID: 32109736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance of clinical isolates of Clostridioides difficile in China and its association with geographical regions and patient age.
    Li H; Li WG; Zhang WZ; Yu SB; Liu ZJ; Zhang X; Wu Y; Lu JX
    Anaerobe; 2019 Dec; 60():102094. PubMed ID: 31499177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
    J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong.
    Chow VCY; Kwong TNY; So EWM; Ho YII; Wong SH; Lai RWM; Chan RCY
    Sci Rep; 2017 Dec; 7(1):17218. PubMed ID: 29222426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.
    Thorpe CM; McDermott LA; Tran MK; Chang J; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Snydman DR
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
    Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
    Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004.
    Taori SK; Hall V; Poxton IR
    J Med Microbiol; 2010 Mar; 59(Pt 3):338-344. PubMed ID: 19942691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of endemic Clostridioides difficile infection in Japan.
    Senoh M; Kato H
    Anaerobe; 2022 Apr; 74():102510. PubMed ID: 34990814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years.
    Lee JH; Lee Y; Lee K; Riley TV; Kim H
    J Med Microbiol; 2014 Jun; 63(Pt 6):819-823. PubMed ID: 24696516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009.
    Akerlund T; Alefjord I; Dohnhammar U; Struwe J; Noren T; Tegmark-Wisell K;
    Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Kullin B; Wojno J; Abratt V; Reid SJ
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):163-175. PubMed ID: 27696234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain.
    Arca-Suárez J; Galán-Sánchez F; Cano-Cano F; García-Santos G; Rodríguez-Iglesias MA
    Anaerobe; 2018 Dec; 54():146-150. PubMed ID: 30261271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of Clostridium difficile in Scotland.
    Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
    J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains.
    Huang H; Weintraub A; Fang H; Wu S; Zhang Y; Nord CE
    Anaerobe; 2010 Dec; 16(6):633-5. PubMed ID: 20849968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole.
    Adler A; Miller-Roll T; Bradenstein R; Block C; Mendelson B; Parizade M; Paitan Y; Schwartz D; Peled N; Carmeli Y; Schwaber MJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):21-4. PubMed ID: 26116225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals.
    Boudjelal Y; Krutova M; Djebbar A; Sebaihia M; Bekara MEA; Rouabhia S; Couturier J; Syed-Zaidi R; Barbut F
    J Infect Dev Ctries; 2022 Jun; 16(6):1055-1063. PubMed ID: 35797301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of the subtype diversity of clinical isolates of Irish Clostridium difficile ribotypes 027 and 078 by repetitive-extragenic palindromic PCR.
    Solomon K; Murray S; Scott L; McDermott S; Drudy D; Martin A; O'Donoghue C; Skally M; Burns K; Fenelon L; Fitzpatrick F; Kyne L; Fanning S
    J Med Microbiol; 2011 Aug; 60(Pt 8):1080-1087. PubMed ID: 21459905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
    Novakova E; Stefkovicova M; Kopilec MG; Novak M; Kotlebova N; Kuijper E; Krutova M
    Int J Infect Dis; 2020 Jan; 90():111-115. PubMed ID: 31707136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.